HEALTH TRIAGE

The company's business model is centered on providing AI-powered software-as-a-service (SaaS) platforms to healthcare providers. Its core offerings target oncology, specifically breast and prostate cancer. One of its flagship products, BreastNegative.ai, is a software platform that assists radiologists in reading mammograms. Given that over 99% of mammograms show no signs of cancer, the system functions as a "first reader," prioritizing potentially problematic cases and, in instances of agreement with the radiologist, can eliminate the need for a second reading, thereby saving time and resources. Another key product is VirtualBiopsy.ai, which offers a non-invasive method for prostate cancer diagnosis. This technology uses AI algorithms and radiomics to assess the presence and aggressiveness of tumors, aiming to reduce the number of invasive biopsies, which have a significant failure rate on the first attempt.

Health Triage is also committed to advancing its AI capabilities through data. The company is developing one of the first data lakes for anonymized and pseudonymized health data to facilitate the continuous improvement of its technologies. This initiative supports its research and development activities and strengthens its collaborations with scientific partners like the Candiolo Cancer Institute, the University of Turin, the Italian Society of Urology (SIU), and the Italian Group for Mammography Screening (GISMa). These partnerships are crucial for the clinical validation of its solutions and for fostering innovation in cancer screening protocols.